Medications like semaglutide and tirzepatide have changed what is possible with weight loss. For many people these drugs are life changing. But there is a quieter part of the story that deserves just as much attention: when the weight comes off, some of it is muscle.

What this article covers

What the science actually shows, why it matters, and what research says you can do to protect strength while losing fat.

Any weight loss costs some muscle.

Here is the first thing worth understanding. Losing muscle during weight loss is not unique to GLP-1 medications. Whenever the body is in an energy deficit, it draws on its reserves, and some lean tissue comes off alongside the fat. A 2024 meta-analysis of calorie restriction confirmed that dieting reliably reduces skeletal muscle mass, even as it produces a larger loss of fat.

What has drawn attention with GLP-1s is the size and speed of the weight loss, and therefore the amount of lean mass that can come with it. In analyses of GLP-1 weight loss, a meaningful share of the total weight lost can be lean mass, up to around 40 percent in some data. Body-composition substudies from the major semaglutide and tirzepatide trials show both fat and lean mass declining as people lose weight.

A note on nuance, because this gets oversimplified. Not all of that lean mass is contractile muscle. Lean mass as measured on a scan also includes water, organ tissue, and connective tissue, and some reduction is a normal, even expected, adaptation to carrying a lighter body. Researchers are still working out how much of the lean loss is benign adaptation and how much is a genuine, unwanted loss of functional muscle. The concern is a disproportionate loss, especially one that leaves someone weaker or more frail.

Why muscle is worth protecting.

Muscle is not only about how you look or how much you can lift. It is closely tied to how well you age. Lower muscle strength is consistently associated with a higher risk of poor health outcomes, to the point that researchers increasingly treat strength as a kind of vital sign. Grip strength, a simple proxy for whole-body strength, has been linked in large international studies to mortality risk. This is an association rather than proof of cause, but it shows up so reliably that it is hard to ignore.

Muscle also supports your metabolism and your day-to-day function: getting up from a chair, climbing stairs, carrying groceries, catching yourself if you stumble, and staying independent. And there is a practical weight-management angle too. Losing a lot of muscle can leave someone smaller but weaker, with a lower metabolic rate, which may make it harder to keep the weight off over time.

Who is most at risk.

Two groups deserve extra care. Older adults are more vulnerable because aging muscle becomes less responsive to protein, a phenomenon called anabolic resistance, so the same protein intake does less to protect muscle than it once did. And anyone losing weight quickly, eating very little protein, or not doing any resistance training is more likely to lose muscle they would rather keep. In other words, the people who most need their strength are often the ones most at risk of losing it during rapid weight loss.

What the science says protects muscle.

The encouraging part is that muscle loss during weight loss is largely preventable, and the two most powerful levers are well established.

The first is enough high-quality protein. When you are eating less overall, every meal matters more, and protein should come first. Older adults in particular appear to need more than the standard recommendation, with expert guidance suggesting roughly 1.0 to 1.2 grams per kilogram per day, and more during illness or significant weight loss. Quality and distribution matter too, not just the daily total: spreading protein across meals and getting enough of the amino acid leucine at each meal helps overcome anabolic resistance. On a GLP-1, where appetite is suppressed and it is easy to under-eat protein without noticing, this is exactly where a protein shake can earn its place.

The second lever, and arguably the most important, is resistance training. Lifting is the signal that tells the body to keep the muscle it has. The evidence here is strong and hopeful: resistance training builds strength and function even in frail older adults, and a striking study showed that combining a higher protein intake with resistance training during a large calorie deficit allowed young men to actually gain lean mass while losing fat at the same time. Similar protein-plus-training protection of muscle and function has been shown in older women during energy restriction. The exact numbers in these studies come from specific populations, so they are best read as proof of the principle rather than a prescription, but the principle is clear: protein plus lifting changes what your body does with a calorie deficit.

A third, gentler point: do not cut calories more aggressively than you need to. A moderate deficit paired with protein and training protects muscle far better than a crash diet that strips it away.

What is still being worked out.

This is an active and fast-moving area, and honesty matters. We do not yet have long-term data on how GLP-1-related muscle loss affects strength and function years down the line, and experts are still debating how much of the lean loss is harmful versus adaptive. There is also a pharmaceutical frontier: early trials are testing whether adding muscle-preserving agents to GLP-1 therapy can shift weight loss toward almost entirely fat. One phase 2 study combining a muscle-preserving drug with semaglutide reported that the large majority of weight lost was fat while lean mass was largely preserved. This is promising but investigational, and not a substitute for the basics of protein and training.

The takeaway

The goal is to lose fat while protecting the muscle that keeps you strong, capable, and independent for the years ahead.

If you are on a GLP-1 or considering one, the most useful things you can do are get enough quality protein, keep or start resistance training, avoid crash-level calorie cuts, and track your strength, not just the number on the scale. And because this involves medication and your individual health, do it in partnership with your doctor or care team.

Educational content only, not medical advice. This article does not replace guidance from your physician, and medication decisions are between you and your care team. Talk to your doctor before changing how you eat or exercise, especially if you take a GLP-1 medication or manage a health condition.

Sources

  1. Neeland IJ, et al. (2024). Body composition changes with GLP-1 receptor agonists. Diabetes, Obesity and Metabolism. doi:10.1111/dom.15728
  2. Conte C, et al. (2024). Muscle mass and GLP-1 receptor agonists: adaptive or maladaptive response to weight loss? Circulation. doi:10.1161/CIRCULATIONAHA.124.067676
  3. Wilding JPH, et al.; STEP-1 Study Group (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine. PMID 33567185
  4. Jastreboff AM, et al.; SURMOUNT-1 Investigators (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine. doi:10.1056/NEJMoa2206038
  5. Meta-analysis (2024). Caloric restriction reduces skeletal muscle mass alongside a larger fat loss; protein and resistance training are protective. PMC11479040
  6. Longland TM, et al.; Phillips SM (2016). Higher protein plus resistance training during a large energy deficit. American Journal of Clinical Nutrition. PMID 26817506
  7. Mojtahedi MC, et al. (2011). Higher protein during energy restriction preserves muscle and physical function in older women. Journals of Gerontology Series A. PMID 21798863
  8. Bauer J, et al. (2013). PROT-AGE protein recommendations for older adults. Journal of the American Medical Directors Association. doi:10.1016/j.jamda.2013.05.021
  9. Traylor DA, Gorissen SHM, Phillips SM (2018). Per-meal protein targets and protein quality for older adults. Advances in Nutrition. PMC5952928
  10. Zaromskyte G, et al.; Witard OC (2021). The leucine trigger is graded, not a strict switch. Frontiers in Nutrition. PMC8295465
  11. Fiatarone MA, et al.; Evans WJ (1990). High-intensity strength training in frail elderly adults. JAMA. PMID 2342214
  12. Resistance-training meta-analyses (2025). Resistance training improves strength, walking speed, and function in older adults. PMC12263917; PMC12112962
  13. Andersen K, et al. (2024). Muscle strength and mortality risk. Journal of Cachexia, Sarcopenia and Muscle. doi:10.1002/jcsm.13619
  14. Leong DP, et al.; Yusuf S (2015). Grip strength and mortality across 17 countries. The Lancet. doi:10.1016/S0140-6736(14)62000-6
  15. Cuthbertson D, et al.; Rennie MJ (2005). Anabolic signaling deficits underlie the reduced protein response of aging muscle. FASEB Journal. PMID 15596483
  16. Anabolic-resistance review (2025). Anabolic resistance is surmountable with a higher per-meal protein dose. PMC12655298
  17. Heymsfield SB, et al.; BELIEVE (ADA 2025). Bimagrumab plus semaglutide phase 2b study. NCT05616013

Protect your muscle while weight comes off.

Apply for personalized one-to-one guidance through the Muscle Longevity System.

Apply for the System